Extracellular matrix tenascin-X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation (Q24290648)

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

The distribution of tenascin-X is distinct and often reciprocal to that of tenascin-C

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Vascular endothelial growth factor B (VEGF-B) binds to VEGF receptor-1 and regulates plasminogen activator activity in endothelial cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Vascular endothelial growth factor B, a novel growth factor for endothelial cells

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Genomic organization of the mouse and human genes for vascular endothelial growth factor B (VEGF-B) and characterization of a second splice isoform

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Localization of VEGF-B in the mouse embryo suggests a paracrine role of the growth factor in the developing vasculature

20 April 2017

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Mapping of the sites for ligand binding and receptor dimerization at the extracellular domain of the vascular endothelial growth factor receptor FLT-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Embryonic expression of tenascin-X suggests a role in limb, muscle, and heart development

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Tenascin–X deficiency is associated with Ehlers–Danlos syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Characterization of the Bovine Tenascin-X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Cell adhesion to tenascin-X mapping of cell adhesion sites and identification of integrin receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Tenascin-C, tenascin-R and tenascin-X: a family of talented proteins in search of functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Molecular characterization and in situ mRNA localization of the neural recognition molecule J1-160/180: a modular structure similar to tenascin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Distinct tissue distribution in pigs of tenascin-X and tenascin-C transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Tenascin-Y: a protein of novel domain structure is secreted by differentiated fibroblasts of muscle connective tissue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Differential expression of tenascin-C and tenascin-X in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Structural analysis of mouse tenascin-X: evolutionary aspects of reduplication of FNIII repeats in the tenascin gene family

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Transcription factor Sp1 activates the expression of the mouse tenascin-X gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Expression of tenascin in developing and adult mouse lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

A novel type of vascular endothelial growth factor, VEGF-E (NZ-7 VEGF), preferentially utilizes KDR/Flk-1 receptor and carries a potent mitotic activity without heparin-binding domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Analysis of the promoter region of the human VEGF-related factor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

Analysis of a peptide hormone–receptor interaction in the yeast two-hybrid system

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

The expression of tenascin-X in developing and adult rat and human eye

21 January 2018

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X

inferred from DOI database lookup

7 January 2021

based on heuristic

Molecular and biological properties of the vascular endothelial growth factor family of proteins

1 reference

https://api.crossref.org/works/10.1046/J.1365-2443.2000.00376.X